RetinaCME
LECTURECME

Advancing Science on Age-Related Macular Degeneration

Author(s)/Faculty: Rishi P. Singh, MD; David S. Boyer, MD; Frank G. Holz, MD, FEBO; SriniVas R. Sadda, MD
Release Date: 1/26/2018Expiration Date: 1/25/2019
Credit Type: CMENumber of Credits: 1.5
Content Type: LectureProvider:
Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it is estimated that more than 5.44 million people will be affected by the disease by 2050, causing significant disability and impacting patient quality of life. Two major forms of AMD exist, atrophic (dry) and exudative (wet), with the atrophic form being more prevalent. Advances in predictive models and diagnostic methodologies allow for the earlier detection of AMD and subsequent timely initiation of optimal therapy. Several options are available for the management of exudative AMD; however, there is not yet an approved treatment to slow or halt the progression of advanced dry AMD. In this CME activity, experts in the field will review and discuss classification criteria of early to late AMD, methods for monitoring and improving visualization, as well as assessment of the efficacy and safety of currently available and novel therapies for the management of patients with AMD.